tetano
Editor, Senior Moderator
Neurology. 2013 Oct 29;81(18):1562-3. doi: 10.1212/01.wnl.0000435294.34351.df.
Influenza vaccines and Guillain-Barre syndrome: The continuing question.
Sejvar JJ.
Source
From the Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
Influenza is a global public health problem, with complications of seasonal influenza resulting in thousands of deaths and substantial morbidity worldwide. Periodically, particularly virulent viral strains emerge, resulting in more infections and fatalities (e.g., influenza A [H1N1] virus and influenza A/H5N1, "bird flu"). Influenza infection may be prevented or mitigated by vaccination; seasonal vaccine is highly effective in reducing clinical illness and limiting viral spread through respiratory droplets.
PMID:
24166961
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/24166961
Influenza vaccines and Guillain-Barre syndrome: The continuing question.
Sejvar JJ.
Source
From the Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
Influenza is a global public health problem, with complications of seasonal influenza resulting in thousands of deaths and substantial morbidity worldwide. Periodically, particularly virulent viral strains emerge, resulting in more infections and fatalities (e.g., influenza A [H1N1] virus and influenza A/H5N1, "bird flu"). Influenza infection may be prevented or mitigated by vaccination; seasonal vaccine is highly effective in reducing clinical illness and limiting viral spread through respiratory droplets.
PMID:
24166961
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/24166961